Fourth SARS-CoV-2 vaccination also protects cancer patients

A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports fourth vaccination for this vulnerable group. However, passive immunization by administering an antibody combination to cancer patients does not seem to provide adequate protection. The study has now been published in the journal JAMA Oncology.